Reverse expression pattern of sirtuin-1 and histone deacetylase-9 in coronary artery disease

References

• Alcendor, R.R., et al., 2007. Sirt1 regulates aging and resistance to oxidative stress in the heart. Circulation research, 100 (10), 1512–1521.
   PubMed Web of Science ®Google Scholar
• Azambuja, M.I., and Levins, R.J.P., 2007. Coronary heart disease (CHD)-one or several diseases? Changes in the prevalence and features of CHD. Perspectives in biology and medicine, 50 (2), 228–242.
   PubMed Web of Science ®Google Scholar
• Azghandi, S., et al., 2015. Deficiency of the stroke relevant HDAC9 gene attenuates atherosclerosis in accord with allele-specific effects at 7p21.1. Stroke, 46 (1), 197–202.
   PubMed Web of Science ®Google Scholar
• Berry, J.M., et al., 2008. Histone deacetylase inhibition in the treatment of heart disease. Expert opinion on drug safety, 7 (1), 53–67.
   PubMed Web of Science ®Google Scholar
• Breitenstein, A., et al., 2013. Peripheral blood monocyte Sirt1 expression is reduced in patients with coronary artery disease. PLoS one, 8 (1), e53106.
   PubMed Web of Science ®Google Scholar
• Cao, Q., et al., 2014. Histone deacetylase 9 represses cholesterol efflux and alternatively activated macrophages in atherosclerosis development. Arteriosclerosis, thrombosis, and vascular biology, 34 (9), 1871–1879.
   PubMed Web of Science ®Google Scholar
• Chan, S.-H., et al., 2017. SIRT1 inhibition causes oxidative stress and inflammation in patients with coronary artery disease. Redox biology, 13, 301–309.
   PubMed Web of Science ®Google Scholar
• Cheng, J., et al., 2015. A TagSNP in SIRT1 gene confers susceptibility to myocardial infarction in a Chinese Han population. PloS one, 10 (2), e0115339.
   PubMed Web of Science ®Google Scholar
• Dichgans, M., et al., 2014. Shared genetic susceptibility to ischemic stroke and coronary artery disease: a genome-wide analysis of common variants. Stroke, 45 (1), 24–36.
   PubMed Web of Science ®Google Scholar
• Ford, E.S., et al., 2007. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. The New England journal of medicine, 356 (23), 2388–2398.
   PubMed Web of Science ®Google Scholar
• Haigis, M.C., and Guarente, L.P., 2006. Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction. Genes & development, 20 (21), 2913–2921.
   PubMed Web of Science ®Google Scholar
• Hatmi, Z., et al., 2007. Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC cardiovascular disorders, 7 (1), 32. doi:10.1186/1471-2261-7-32
   PubMedGoogle Scholar
• Hauser, E.R., et al., 2004. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. The American journal of human genetics, 75 (3), 436–447.
   PubMed Web of Science ®Google Scholar
• Joseph, P.G., Pare, G., and Anand, S.S., 2013. Exploring gene-environment relationships in cardiovascular disease. The Canadian journal of cardiology, 29 (1), 37–45.
   PubMed Web of Science ®Google Scholar
• Khera, A.V., and Kathiresan, S., 2017. Genetics of coronary artery disease: discovery, biology and clinical translation. Nature reviews: genetics, 18 (6), 331–344.
   PubMed Web of Science ®Google Scholar
• Kilic, U., et al., 2014. SIRT1 gene polymorphisms affect the protein expression in cardiovascular diseases. PloS one, 9 (2), e90428.
   PubMed Web of Science ®Google Scholar
• Li, Y., et al., 2016. In patients with coronary artery disease and type 2 diabetes. Biomed research international, 2016, 1–7.
   Web of Science ®Google Scholar
• Lloyd-Jones, D.M., et al., 2004. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA, 291 (18), 2204–2211.
   PubMed Web of Science ®Google Scholar
• Lozano, R., et al., 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (London, England), 380 (9859), 2095–2128.
   PubMed Web of Science ®Google Scholar
• Marenberg, M.E., et al., 1994. Genetic susceptibility to death from coronary heart disease in a study of twins. The New England journal of medicine, 330 (15), 1041–1046.
   PubMed Web of Science ®Google Scholar
• Markus, H.S., et al., 2013. Evidence HDAC9 genetic variant associated with ischemic stroke increases risk via promoting carotid atherosclerosis. Stroke, 44 (5), 1220–1225.
   PubMed Web of Science ®Google Scholar
• Pan, L., Lu, J., and Huang, B.J., 2007. HDAC inhibitors: a potential new category of anti-tumor agents. Cellular & molecular immunology, 4 (5), 337–343.
   PubMed Web of Science ®Google Scholar
• Peeters, A.V., et al., 2008. Association of SIRT1 gene variation with visceral obesity. Human genetics, 124 (4), 431–436.
   PubMed Web of Science ®Google Scholar
• Pillarisetti, S.J., 2008. A review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases. Recent patents on cardiovascular drug discovery, 3 (3), 156–164.
   PubMedGoogle Scholar
• Potente, M., and Dimmeler, S., 2008. Emerging roles of SIRT1 in vascular endothelial homeostasis. Cell cycle, 7 (14), 2117–2122.
   PubMed Web of Science ®Google Scholar
• Sharma, P., et al., 2008. Detection of altered global DNA methylation in coronary artery disease patients. DNA and cell biology, 27 (7), 357–365.
   PubMed Web of Science ®Google Scholar
• Shen, G.-Q., Archacki, S., and Wang, Q., 2004. The molecular genetics of coronary artery disease and myocardial infarction. Current atherosclerosis reports, 6 (4), 129–141.
   Google Scholar
• Shimoyama, Y., et al., 2012. SIRTUIN 1 gene polymorphisms are associated with cholesterol metabolism and coronary artery calcification in Japanese hemodialysis patients. Journal of renal nutrition, 22 (1), 114–119.
   PubMed Web of Science ®Google Scholar
• Sohrabifar, N., et al., 2019. MicroRNA-copy number variations in coronary artery disease patients with or without type 2 diabetes mellitus. Archives of physiology and biochemistry, 1–7.
   PubMed Web of Science ®Google Scholar
• Sohrabifar, N., et al., 2020. Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus. Archives of physiology and biochemistry, 1–8.
   PubMed Web of Science ®Google Scholar
• Sun, X., et al., 2012. Expression of SIRT1 in right auricle tissues and the relationship with oxidative stress in patients with atrial fibrillation. Chinese journal of cellular and molecular immunology, 28 (9), 972–974.
   Google Scholar
• The CARDIoGRAMplusC4D Consortium, 2013. Large-scale association analysis identifies new risk loci for coronary artery disease. Nature genetics, 45, 25–33.
   Google Scholar
• Topol, E.J., and Califf, R.M., 2007. Textbook of cardiovascular medicine. Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• Turan, N., et al., 2010. Explaining inter-individual variability in phenotype: is epigenetics up to the challenge? Epigenetics, 5 (1), 16–19.
   PubMed Web of Science ®Google Scholar
• Wang, Q., 2005. Molecular genetics of coronary artery disease. Current opinion in cardiology, 20 (3), 182–188.
   PubMed Web of Science ®Google Scholar
• Wang, X-B., et al., 2016. HDAC9 variant Rs2107595 modifies susceptibility to coronary artery disease and the severity of coronary atherosclerosis in a Chinese Han population. Mismatch, 11 (8), e0160449.
   Google Scholar
• Won, H.-H., et al., 2015. Disproportionate contributions of select genomic compartments and cell types to genetic risk for coronary artery disease. PLoS genetics, 11 (10), e1005622.
   PubMed Web of Science ®Google Scholar
• Yamamoto, H., Schoonjans, K., and Auwerx, J., 2007. Sirtuin functions in health and disease. Molecular endocrinology, 21 (8), 1745–1755.
   PubMedGoogle Scholar
• Yoon, S., and Eom, G.H., 2016. HDAC and HDAC inhibitor: from cancer to cardiovascular diseases. Chonnam medical journal, 52 (1), 1–11.
   PubMedGoogle Scholar
• Zhang, C.L., et al., 2002. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell, 110 (4), 479–488.
   PubMed Web of Science ®Google Scholar
• Zhu, X., et al., 2011. Activation of Sirt1 by resveratrol inhibits TNF-α induced inflammation in fibroblasts. PloS one, 6 (11), e27081.
   PubMed Web of Science ®Google Scholar